2026 Trends in Drug Benefit Design Report
PSG announces the results of its extensive research on the latest trends in drug benefit design. Plan sponsors face complex decisions and challenges…
Read Post
Insights
Categories
Topics
Categories
Topics
Turning Complexity Into Confidence With Smarter Guarantee Monitoring
Payers can reduce reliance on PBM self-reporting and gain confidence in their guarantee performance. The Challenge Monitoring PBM pricing guarantees across pharmacy networks…
Read Post
NCPDP D.0 to F6 Compliance: What Payers Need to Know
Payer Considerations and Next Steps for the NCPDP D.0 to F6 Compliance Key Points: This is more than compliance. F6 is an opportunity to…
Read Post
2026 Drugs to Watch: Forecasting Pharmacy Impact with Artemetrx
The specialty drug pipeline is accelerating—and the financial implications for plans are significant. With new GLP-1 formulations, MASH therapies, and cell and gene therapy…
Read Post
2025 PBM Satisfaction: Navigating Change and Opportunity in Pharmacy Benefit Management
How Payer Feedback Can Help Improve the Pharmacy Benefit Management Industry As pharmacy benefit management continues to evolve, the latest findings from the…
Read Post
Beyond the Black Box: Reassessing HRT for Modern Women
For over two decades, hormone replacement therapy (HRT) has been shadowed by cautionary tales and black box warnings. These warnings – rooted in early…
Read Post
Comprehensive Strategies for Effective Pharmacy Benefit Claims Validation
Avoid Costly Errors with Proactive Pharmacy Benefit Claims Validation Key Points Claims validation helps uncover discrepancies that impact plan performance and member experience. Thorough…
Read Post
Navigating the Medicare Transaction Facilitator: A Game-Changer for PBMs, Medicare Part D Plans, and Pharmacies
Operational Excellence is Essential for Plans and PBMs Key Points The Medicare Transaction Facilitator (MTF), fully operational in 2026, requires plans and PBMs to…
Read Post
Integrated Insights, Clinical Connections: Hereditary Angiodema (HAE)
Three New HAE Therapies May Increase Benefit Spend For Payers Hereditary Angioedema, or HAE, is a genetic condition that is very rare and…
Read Post
Placing Value on Value-Based Care
Key Points Value-based care (VBC) challenges the quantity over quality model of healthcare. Technology can enable payers to invest and focus on value-based care…
Read Post
Pharmaceutical Strategies Group Publishes 2025 Pharmacy Benefit Manager Customer Satisfaction Report
Satisfaction with PBMs Hits Historic Lows, Appetite for Change Surges DALLAS, TX – September 23, 2025 – For over two decades, Pharmaceutical Strategies Group…
Read Post
2025 Pharmacy Benefit Manager (PBM) Customer Satisfaction Report
PSG’s PBM Customer Satisfaction Report provides the most in-depth picture of the PBM landscape today, leveraging perspectives taken directly from employer and health plan…
Read Post